Kalobios Pharmaceuticals Inc

* Kalobios emerges from chapter 11 bankruptcy

* Receives $14 million in equity financing to helprecapitalize its business

* Kalobios pharmaceuticals inc says under terms of agreementwith savant, company has made an upfront payment of $3 million

* Acquired rights from savant neglected diseases llc todevelop benznidazole for treatment of chagas disease

* Says in connection with bankruptcy exit,debtor-in-possession loan converted into shares of kalobioscommon stock

* Say also issued to savant a warrant to purchase 200,000shares of kalobios common stock

* Exit equity financing of $11 million comes on top of a $3million debtor-in-possession loan funded in may 2016

* Kalobios pharmaceuticals inc says durrant and ronaldbarliant will remain on board of directors

* Says ezra friedberg and timothy morris will also joinboard of directors as designees of investors

* In connection with bankruptcy exit, debtor-in-possessionloan converted into shares of kalobios common stock

* Black horse capital managing member dr. Dale chappell willjoin kalobios board of directors effective immediatelySource text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)